In vitro antimicrobial susceptibility pattern among stenotrophomonas maltophilia strains isolated from clinical specimens

Basit Öğe Kaydı
dc.contributor.authorTekin A.
dc.contributor.authorDal T.
dc.contributor.authorTekin R.
dc.contributor.authorDeveci Ö.
dc.contributor.authorDemirkaya S.
dc.contributor.authorMete M.
dc.contributor.authorDayan S.
dc.date.accessioned2024-04-24T18:43:46Z
dc.date.available2024-04-24T18:43:46Z
dc.date.issued2014
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: In this study, the determination of in vitro antimicrobial susceptibility rates among Stenotrophomonas maltophilia strains isolated from clinical specimens was aimed. Method: A total of 60 S. maltophilia strains isolated from various clinical specimens sent to Dicle University Hospital clinical microbiology laboratory between January 2006 and September 2011 were included retrospectively in this study. Urine samples were inoculated onto 5% sheep blood agar and Eosin-Methylene Blue (EMB) agar media, quantitatively; other clinical samples were inoculated, qualitatively. Identification of S. maltophilia isolates was performed by conventional methods and fully automated microbiology system. Antimicrobial susceptibility tests were performed by Kirby-Bauer’s disk diffusion method and by broth dilution. Results: A total of 60 S. maltophilia strains isolated from clinical specimens as 24 urine, 15 blood, 11 sputum, four synovial fluids, three cerebrospinal fluids, two wound swabs and one middle ear materials. The resistance rates against antibiotics were detected as 85% (n=51) for piperacillin-tazobactam, 75% (n=45) for levofloxacin, 73% (n=44) for ciprofloxacin, 57% (n=34) for trimethoprim-sulfamethoxazole, 5% (n=3) for meropenem and imipenem, and 0% (n=0) for amikacin. Conclusion: In this study, it was detected that piperacillin-tazobactam can be used as an alternative option other than trimethoprim-sulfamethoxazole, for the treatment of infections due to S. maltophilia at least in our region. © 2012 Düzce Medical Journal.en_US
dc.identifier.endpage7en_US
dc.identifier.issn1307-671X
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-84940644601en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage4en_US
dc.identifier.urihttps://hdl.handle.net/11468/24366
dc.identifier.volume16en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.publisherDuzce University Medical Schoolen_US
dc.relation.ispartofDuzce Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIn Vitroen_US
dc.subjectLevofloxacinen_US
dc.subjectStenotrophomonas Maltophiliaen_US
dc.subjectTrimethoprim-Sulfamethoxazoleen_US
dc.titleIn vitro antimicrobial susceptibility pattern among stenotrophomonas maltophilia strains isolated from clinical specimensen_US
dc.title.alternativeKlinik örneklerden izole edilen stenotrophomonas maltophilia suşlarinin in vitro antibiyotik duyarlilik paternien_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu